"The Potential of Clostridium butyricum to Preserve Gut Health, and to Mitigate Non-AIDS Comorbidities in People Living with HIV"

作者全名："Yang, Qiyu; Zaongo, Silvere D.; Zhu, Lijiao; Yan, Jiangyu; Yang, Jiadan; Ouyang, Jing"

作者地址："[Yang, Qiyu] Chongqing Univ, Dept Radiat Oncol, Canc Hosp, Chongqing, Peoples R China; [Yang, Qiyu] Chongqing Canc Inst, Chongqing, Peoples R China; [Yang, Qiyu] Chongqing Canc Hosp, Chongqing, Peoples R China; [Zaongo, Silvere D.] Chongqing Publ Hlth Med Ctr, Dept Infect Dis, Chongqing, Peoples R China; [Zaongo, Silvere D.; Zhu, Lijiao; Yan, Jiangyu; Ouyang, Jing] Chongqing Publ Hlth Med Ctr, Clin Res Ctr, Chongqing, Peoples R China; [Yang, Jiadan] Chongqing Med Univ, Dept Pharm, Affiliated Hosp 1, Chongqing, Peoples R China"

通信作者："Ouyang, J (通讯作者)，Chongqing Publ Hlth Med Ctr, Clin Res Ctr, Chongqing, Peoples R China.; Yang, JD (通讯作者)，Chongqing Med Univ, Dept Pharm, Affiliated Hosp 1, Chongqing, Peoples R China."

来源：PROBIOTICS AND ANTIMICROBIAL PROTEINS

ESI学科分类：MICROBIOLOGY

WOS号：WOS:001160207800001

JCR分区：Q1

影响因子：4.9

年份：2024

卷号：　

期号：　

开始页：　

结束页：　

文献类型：Review; Early Access

关键词：Clostridium butyricum; Inflammation; Gut; HIV; Cancer

摘要："A dramatic reduction in mortality among people living with HIV (PLWH) has been achieved during the modern antiretroviral therapy (ART) era. However, ART does not restore gut barrier function even after long-term viral suppression, allowing microbial products to enter the systemic blood circulation and induce chronic immune activation. In PLWH, a chronic state of systemic inflammation exists and persists, which increases the risk of development of inflammation-associated non-AIDS comorbidities such as metabolic disorders, cardiovascular diseases, and cancer. Clostridium butyricum is a human butyrate-producing symbiont present in the gut microbiome. Convergent evidence has demonstrated favorable effects of C. butyricum for gastrointestinal health, including maintenance of the structural and functional integrity of the gut barrier, inhibition of pathogenic bacteria within the intestine, and reduction of microbial translocation. Moreover, C. butyricum supplementation has been observed to have a positive effect on various inflammation-related diseases such as diabetes, ulcerative colitis, and cancer, which are also recognized as non-AIDS comorbidities associated with epithelial gut damage. There is currently scant published research in the literature, focusing on the influence of C. butyricum in the gut of PLWH. In this hypothesis review, we speculate the use of C. butyricum as a probiotic oral supplementation may well emerge as a potential future synergistic adjunctive strategy in PLWH, in tandem with ART, to restore and consolidate intestinal barrier integrity, repair the leaky gut, prevent microbial translocation from the gut, and reduce both gut and systemic inflammation, with the ultimate objective of decreasing the risk for development of non-AIDS comorbidities in PLWH."

基金机构："Medical Research Projects of Chongqing Science & Technology Bureau [CSTB2022BSXM-JCX0081, CSTB2023TIAD-KPX0063-3, CSTB2023NSCQ-MSX0392]; Joint Project of Chongqing Health Commission and Science and Technology Bureau [2024ZDXM015, 2024GDRC012]; Chongqing Public Health Medical Center Research Initiation Fund [KYLW202321]"

基金资助正文："This study was funded by the Medical Research Projects (No. CSTB2022BSXM-JCX0081, No. CSTB2023TIAD-KPX0063-3, and No. CSTB2023NSCQ-MSX0392) of Chongqing Science & Technology Bureau, Joint Project of Chongqing Health Commission and Science and Technology Bureau (Nos. 2024ZDXM015 and 2024GDRC012), and the Chongqing Public Health Medical Center Research Initiation Fund (KYLW202321)."